Seal Shield Unveils Comprehensive UV-C Sanitization Technology at AORN 2026
At the AORN 2026 Global Surgical Conference & Expo held in New Orleans, Seal Shield LLC, a key player in the field of hygienic medical-grade devices, has announced the launch of an extensive UV-C sanitization solution suite. This new suite features the advanced capabilities of Vioguard, which Seal Shield recently acquired, reinforcing its dedication to hygiene standards and the reduction of cross-contamination risks within healthcare environments.
Founded by former Microsoft employees in 2008, Vioguard pioneered the utilization of ultraviolet (UV-C) light for sanitizing shared devices, a crucial innovation in today's health-sensitive atmosphere. The effectiveness of Vioguard's UV-C technology has been validated by independent research conducted by notable institutions, including the Louis Stokes Cleveland VA Medical Center and Case Western Reserve University. Their studies confirmed that Vioguard's solutions effectively inactivate a wide array of pathogens—ranging from the Ebola virus to various influenza strains and Clostridium difficile (C. diff).
Brad Whitchurch, CEO of Seal Shield, expressed enthusiasm about integrating Vioguard's technologies into their existing portfolio: